Concepedia

Kelly M. Standifer

KM

46

Publications

2.3K

Citations

23

H-Index

1987

Active since

Affiliations

University of Houston(Current)

Memorial Sloan Kettering Cancer Center

University of Oklahoma Health Sciences Center

Cornell University

Kelly M. Standifer is an author at University of Houston specializing in medicine, pharmacology, and neuropharmacology.

ORCID

Top concepts

Publications per year

1987–2021

46

Publications

46

Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite.

Dennis Paúl, Kelly M. Standifer, Charles E. Inturrisi et al. · Journal of Pharmacology and Experimental Therapeutics · 1989 · 394 citations

Selective loss of δ opioid analgesia and binding by antisense oligodeoxynucleotides to a δ opioid receptor

Kelly M. Standifer, Chih‐Cheng Chien, Claes Wahlested et al. · Neuron · 1994 · 198 citations

, , +13

Gender effects and central opioid analgesia

Karen L. Kepler, Kelly M. Standifer, Dennis Paúl et al. · Pain · 1991 · 183 citations

, , +21

Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor.

Ying-Xin Pan, Jun Cheng, Jin Xu et al. · Molecular Pharmacology · 1995 · 154 citations

Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G protein alpha subunits.

Kelly M. Standifer, Grace C. Rossi, Gavril W. Pasternak · Molecular Pharmacology · 1996 · 117 citations

Rows per page

1–5 of 46